Description
The changing role of the axillary dissection in the treatment of breast cancer
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: The changing role of the axillary dissection in the treatment of breast cancer
€3.03
